ViewRay Past Earnings Performance
Past criteria checks 0/6
ViewRay's earnings have been declining at an average annual rate of -6.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 3% per year.
Key information
-6.6%
Earnings growth rate
13.7%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 3.0% |
Return on equity | -199.8% |
Net Margin | -104.3% |
Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Market Cool On ViewRay, Inc.'s (NASDAQ:VRAY) Revenues Pushing Shares 63% Lower
Apr 17Health Check: How Prudently Does ViewRay (NASDAQ:VRAY) Use Debt?
Dec 24ViewRay MRI-guided radiation therapy selected by SUNY upstate cancer center
Oct 06ViewRay's MRI-guided radiation therapy gets approval in China
Sep 07ViewRay MRI-guided radiation therapy selected by VA Houston Healthcare System
Aug 23ViewRay: Insider Buying In This $3 Stock
May 15Health Check: How Prudently Does ViewRay (NASDAQ:VRAY) Use Debt?
Apr 22Is ViewRay (NASDAQ:VRAY) Using Debt Sensibly?
Aug 09ViewRay, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 08Read This Before Selling ViewRay, Inc. (NASDAQ:VRAY) Shares
Mar 03How Many ViewRay, Inc. (NASDAQ:VRAY) Shares Do Institutions Own?
Jan 27ViewRay rallies premarket on Q4 preliminary revenue
Jan 04ViewRay's (NASDAQ:VRAY) Stock Price Has Reduced 56% In The Past Three Years
Dec 22ViewRay +10.6% on CEO acquiring shares
Nov 12Revenue & Expenses Breakdown
How ViewRay makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 23 | 106 | -110 | 83 | 33 |
31 Dec 22 | 102 | -107 | 83 | 32 |
30 Sep 22 | 88 | -107 | 81 | 33 |
30 Jun 22 | 81 | -106 | 77 | 34 |
31 Mar 22 | 73 | -109 | 73 | 33 |
31 Dec 21 | 70 | -110 | 72 | 32 |
30 Sep 21 | 68 | -109 | 70 | 30 |
30 Jun 21 | 59 | -112 | 72 | 27 |
31 Mar 21 | 58 | -107 | 74 | 25 |
31 Dec 20 | 57 | -108 | 77 | 25 |
30 Sep 20 | 55 | -117 | 80 | 24 |
30 Jun 20 | 66 | -110 | 88 | 25 |
31 Mar 20 | 82 | -114 | 93 | 25 |
31 Dec 19 | 88 | -120 | 92 | 24 |
30 Sep 19 | 92 | -102 | 88 | 21 |
30 Jun 19 | 89 | -114 | 81 | 20 |
31 Mar 19 | 75 | -105 | 72 | 18 |
31 Dec 18 | 81 | -79 | 65 | 17 |
30 Sep 18 | 80 | -87 | 59 | 17 |
30 Jun 18 | 75 | -65 | 49 | 17 |
31 Mar 18 | 59 | -52 | 45 | 16 |
31 Dec 17 | 34 | -72 | 40 | 15 |
30 Sep 17 | 30 | -59 | 34 | 12 |
30 Jun 17 | 18 | -61 | 32 | 11 |
31 Mar 17 | 18 | -65 | 30 | 11 |
31 Dec 16 | 22 | -51 | 29 | 11 |
30 Sep 16 | 11 | -54 | 30 | 12 |
30 Jun 16 | 16 | -50 | 28 | 12 |
31 Mar 16 | 16 | -50 | 29 | 12 |
31 Dec 15 | 10 | -45 | 27 | 10 |
30 Sep 15 | 6 | -41 | 26 | 9 |
30 Jun 15 | 4 | -38 | 25 | 9 |
31 Mar 15 | 5 | -34 | 20 | 9 |
31 Dec 14 | 6 | -34 | 19 | 9 |
30 Sep 14 | 8 | -32 | 16 | 10 |
31 Dec 13 | 3 | -28 | 13 | 9 |
31 Dec 12 | 2 | -25 | 10 | 8 |
Quality Earnings: VRAY.Q is currently unprofitable.
Growing Profit Margin: VRAY.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VRAY.Q is unprofitable, and losses have increased over the past 5 years at a rate of 6.6% per year.
Accelerating Growth: Unable to compare VRAY.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VRAY.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Return on Equity
High ROE: VRAY.Q has a negative Return on Equity (-199.82%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/10/26 00:17 |
End of Day Share Price | 2023/10/26 00:00 |
Earnings | 2023/03/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ViewRay, Inc. is covered by 12 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jason Bednar | Baird |
Andrew D'Silva | B. Riley Securities, Inc. |
Michael Gorman | BTIG |